751 results on '"Cattoir, Vincent"'
Search Results
152. Prevalence of qnr genes in Salmonella in France
153. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid
154. A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.
155. Streptogramins for the treatment of infections caused by Gram-positive pathogens.
156. In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates
157. Faculty Opinions recommendation of An enzymatic pathway in the human gut microbiome that converts A to universal O type blood.
158. Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis
159. Faculty Opinions recommendation of Intestinal Bile Acids Induce a Morphotype Switch in Vancomycin-Resistant Enterococcus that Facilitates Intestinal Colonization.
160. Unexpected activity of oral fosfomycin against resistant strains ofEscherichia coliin murine pyelonephritis
161. Colistin heteroresistance in Enterobacter cloacae is regulated by PhoPQ‐dependent 4‐amino‐4‐deoxy‐ l ‐arabinose addition to lipid A
162. Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006–16
163. Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges
164. Resistance to Glycopeptide Antibiotics
165. Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
166. Colistin heteroresistance in Enterobacter cloacae is mediated by PmrAB-independent 4-amino-4-deoxy-L-arabinose addition to lipid A
167. Faculty Opinions recommendation of Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation.
168. How is fosfomycin resistance developed in Escherichia coli?
169. Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes
170. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study
171. Rapid detection of Pseudomonas aeruginosa from positive blood cultures by quantitative PCR
172. Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
173. Brachyspira pilosicoli bloodstream infections: Case report and review of the literature
174. Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report.
175. In vivo emergence of rifampicin resistance by rpoB mutation in Listeria monocytogenes during therapy of prosthetic joint infection
176. Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates
177. Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance
178. Large Eddy simulation of a supersonic ejector
179. Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia.
180. Helcococcus kunzii methyltransferase Erm(47) responsible for MLSB resistance is induced by diverse ribosome-targeting antibiotics.
181. A nationwide survey on involvement of clinical microbiologists in antibiotic stewardship programmes in large French hospitals.
182. Elective distribution of resistance to beta-lactams among Enterobacter cloacae genetic clusters
183. In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different β-Lactam Resistance Phenotypes
184. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections
185. Bacterial Adaptation to Antibiotics through Regulatory RNAs
186. Exploring the Antimicrobial Action of Quaternary Amines against Acinetobacter baumannii
187. Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium
188. Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate
189. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis
190. Faculty Opinions recommendation of Peripheral modifications of [Ψ[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics.
191. Nationwide molecular epidemiology of methicillin-resistant Staphylococcus aureus responsible for horse infections in France
192. Subinhibitory Concentrations of Ciprofloxacin Enhance Antimicrobial Resistance and Pathogenicity of Enterococcus faecium
193. Erratum to ‘Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae’ [International Journal of Antimicrobial Agents 49/1 67–73]
194. Decrease of Staphylococcus aureus Virulence by Helcococcus kunzii in a Caenorhabditis elegans Model
195. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae
196. Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis
197. Intrinsic colistin resistance
198. Abstract IA17: Gut microbiota controls immuneresponses during cancer therapy
199. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
200. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.